[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364426-105":59,"doc-detail-364426-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","wnt-pathway-targeted-therapy-in-gastrointestinal-cancers-integrating-benchside-insights-with-bedside-applications","Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers - Integrating Benchside Insights with Bedside Applications","","The Wnt signaling pathway is critical in the onset and progression of gastrointestinal cancers. Mutations in key components such as APC or β-catenin can drive uncontrolled proliferation, survival, tumor initiation, growth, metastasis, and resistance across GI malignancies including colorectal, gastric, pancreatic, and hepatocellular cancers. The review surveys dysregulated Wnt signaling in GI cancer pathogenesis and evaluates therapeutic potential by integrating preclinical findings on Wnt pathway inhibitors with completed and ongoing clinical trials, while addressing major barriers to effective clinical translation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/wnt-pathway-targeted-therapy-in-gastrointestinal-cancers-integrating-benchside-insights-with-bedside-applications/364426/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/wnt-pathway-targeted-therapy-in-gastrointestinal-cancers-integrating-benchside-insights-with-bedside-applications/364426.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the Wnt signaling pathway contribute to gastrointestinal cancer development?","Question",{"text":113,"@type":114},"Dysregulation of Wnt signaling, often from mutations in components like APC or β-catenin, promotes uncontrolled cell proliferation and survival. It drives tumor initiation and growth and is associated with metastasis and resistance across multiple GI cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which gastrointestinal cancer types are discussed in relation to Wnt-targeted therapy?",{"text":118,"@type":114},"The document focuses on colorectal cancer and also covers other GI cancers including gastric, pancreatic, and hepatocellular carcinomas, highlighting how aberrant Wnt signaling contributes to their progression.",{"name":120,"@type":111,"acceptedAnswer":121},"What does the review integrate to support Wnt pathway-targeted treatments?",{"text":122,"@type":114},"It summarizes and integrates preclinical evidence showing therapeutic efficacy of potent Wnt pathway inhibitors and connects these findings to completed and ongoing clinical trials. It also discusses challenges that may affect clinical translation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},364426,1790182388,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Review  \nWnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications  \nAnirudh Nayak†, Hannah Streiff †, Ivan Gonzalez †, Oluwabomi Oluwatomi Adekoya, Itzcoatl Silva and Anitha Kota Shenoy *,‡  \nAcademic Editor: Kermit L. Carraway  \nReceived: 9 December 2024  \nRevised: 5 January 2025  \nAccepted: 7 January 2025  \nPublished: 24 January 2025  \nCitation: Nayak, A.; Streiff, H.; Gonzalez, I.; Adekoya, O.O.; Silva, I.; Shenoy, A.K. Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications. Cells 2025, 14, 178. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cells14030178  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nMaster of Science in Biomedical Sciences Program, California Health Sciences University, Clovis, CA 93612, USA;  \n[nayak2756@chsu.edu](nayak2756@chsu.edu) (A.N.); [streiff2694@chsu.edu](streiff2694@chsu.edu) (H.S.); [gonzalez2754@chsu.edu](gonzalez2754@chsu.edu) (I.G.);  \n[adekoya2696@chsu.edu](adekoya2696@chsu.edu) (O.O.A.); [silva2752@chsu.edu](silva2752@chsu.edu) (I.S.)  \n* Correspondence: [ashenoy@tamu.edu](ashenoy@tamu.edu)  \n† These authors contributed equally to this work.  \n‡ Current address: Department of Medical Education, College of Medicine, Texas A&M University, Bryan, TX 77807, USA.  \nAbstract: The Wnt signaling pathway is critical in the onset and progression of gastrointestinal (GI) cancers. Anomalies in this pathway, often stemming from mutations in critical components such as adenomatous polyposis coli (APC) or β-catenin, lead to uncontrolled cell proliferation and survival. In the case of colorectal cancer, dysregulation of the Wnt pathway drives tumor initiation and growth. Similarly, aberrant Wnt signaling contributes to tumor development, metastasis, and resistance to therapy in other GI cancers, such as gastric, pancreatic, and hepatocellular carcinomas. Targeting the Wnt pathway or its downstream effectors has emerged as a promising therapeutic strategy for combating these highly aggressive GI malignancies. Here, we review the dysregulation of the Wnt signaling pathway in the pathogenesis of GI cancers and further explore the therapeutic potential of targeting the various components of the Wnt pathway. Furthermore, we summarize and integrate the preclinical evidence supporting the therapeutic efficacy of potent Wnt pathway inhibitors with completed and ongoing clinical trials in GI cancers. Additionally, we discuss the challenges of Wnt pathway-targeted therapies in GI cancers to overcome these concerns for effective clinical translation.  \nKeywords: gastrointestinal cancers; Wnt signaling pathway; β-catenin; clinical trials; colorectal cancer; pancreatic cancer; gastric cancer; hepatocellular carcinoma  \n1. Introduction  \nCancer is a complex and multifaceted disease characterized by the uncontrolled proliferation of transformed cells, which possess the capacity to invade surrounding tissues, metastasize to distant organs, and adapt through natural selection [1,2] . Cancer is the second leading cause of death in the US and among the three leading causes of death worldwide [3,4]. According to “Cancer Statistics”, in 2024, it is projected that approximately 2,001,140 new cancer cases will be diagnosed in the US. Gastrointestinal (GI) cancers, which include esophageal, stomach, liver, pancreatic, and colorectal cancers (CRCs), collectively are expected to be among the leading causes of cancer-related deaths [5,6] . CRC is the most commonly diagnosed and deadliest form of GI cancer, followed by pancreatic cancer, which has a dismal five-year survival rate of only 13% in","cbCainyb8xn98Ulg","https://ap.wps.com/l/cbCainyb8xn98Ulg","pdf",2212613,27,"English","# Introduction\n## Cancer burden and GI cancer overview\n## Conventional and emerging therapies\n## Mechanisms of resistance and need for new strategies\n## Role of Wnt signaling in GI cancers\n## Review scope: preclinical evidence and clinical trials","[{\"question\":\"How does the Wnt signaling pathway contribute to gastrointestinal cancer development?\",\"answer\":\"Dysregulation of Wnt signaling, often from mutations in components like APC or β-catenin, promotes uncontrolled cell proliferation and survival. It drives tumor initiation and growth and is associated with metastasis and resistance across multiple GI cancers.\"},{\"question\":\"Which gastrointestinal cancer types are discussed in relation to Wnt-targeted therapy?\",\"answer\":\"The document focuses on colorectal cancer and also covers other GI cancers including gastric, pancreatic, and hepatocellular carcinomas, highlighting how aberrant Wnt signaling contributes to their progression.\"},{\"question\":\"What does the review integrate to support Wnt pathway-targeted treatments?\",\"answer\":\"It summarizes and integrates preclinical evidence showing therapeutic efficacy of potent Wnt pathway inhibitors and connects these findings to completed and ongoing clinical trials. It also discusses challenges that may affect clinical translation.\"}]","Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers - Integrating Benchside Insights with Bedside Applications | PDF",1790157514,68,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2479b4c3736b2b774283f077cec378af.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/867580b6aef7cf910e15db88eb1b5361.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2fb8485a0b4cc473faf16442dc10e37.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0c32adebee211924977f44635d0e694.webp",980,1385]